Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array

Oncogene

Volumn 28, Issue 33, 2009, Pages 2969-2978

  Radpour, R ^a   Kohler, C ^a   Haghighi, M M ^b   Fan, A X C ^a   Holzgreve, W ^c   Zhong, X Y ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Breast cancer; DNA methylation; MALDITOF; Mass spectrometry

Indexed keywords

APC; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 6; BRCA1 PROTEIN; BRCA2 PROTEIN; CADHERIN; CADHERIN 1; CARRIER PROTEINS AND BINDING PROTEINS; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUTATHIONE TRANSFERASE P1; NUCLEOSIDE DIPHOSPHATE KINASE A; PROGESTERONE RECEPTOR; PROSTASIN; PROTEIN BIN1; PROTEIN CST6; PROTEIN DAPKI; PROTEIN NES1; PROTEIN P16; PROTEIN P21; PROTEIN P53; PROTEIN RAR B; PROTEIN SRBC; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA FINGERPRINTING; DNA METHYLATION; GENE EXPRESSION; GENE SEQUENCE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; UNTRANSLATED REGION;

ADULT; AGED; AUTOMATION; BREAST NEOPLASMS; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSCRIPTION FACTORS;

EID: 69249129052     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.149     Document Type: Article

References (20)

1. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M et al. (2006). DNA methylation profiling of human chromosomes 6 20 and 22. Nat Genet 38: 1378-1385.
2. Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G et al. (2005). Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA 102: 15785-15790.
3. Ehrich M, Turner J, Gibbs P, Lipton L, Giovanneti M, Cantor C et al. (2008). Cytosine methylation profiling of cancer cell lines. Proc Natl Acad Sci USA 105: 4844-4849.
4. Issa JP. (2004). CpG island methylator phenotype in cancer. Nat Rev Cancer 4: 988-993.
5. Jones PA, Baylin SB. (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428.
6. Kangaspeska S, Stride B, Metivier R, Polycarpou-Schwarz M, Ibberson D, Carmouche RP et al. (2008). Transient cyclical methylation of promoter DNA. Nature 452: 112-115.
7. Laird PW. (2003). The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266.
8. Li LC, Dahiya R. (2002). MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427-1431.
9. Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M et al. (2008). DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 54: 414-423.
10. Metivier R, Gallais R, Tiffoche C, Le Peron C, Jurkowska RZ, Carmouche RP et al. (2008). Cyclical DNA methylation of a transcriptionally active promoter. Nature 452: 45-50.
11. Nakayama H, Hibi K, Takase T, Yamazaki T, Kasai Y, Ito K et al. (2003). Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients. Int J Cancer 105: 491-493.
12. Radpour R, Haghighi MM, Fan AX, Torbati PM, Hahn S, Holzgreve W et al. (2008). High-throughput hacking of the methylation patterns in breast cancer by in vitro transcription and thymidinespecific cleavage mass array on MALDI-TOF silico-chip. Mol Cancer Res 6: 1702-1709.
13. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
14. Srinivasan M, Sedmak D, Jewell S. (2002). Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 161: 1961-1971.
15. Stanssens P, Zabeau M, Meersseman G, Remes G, Gansemans Y, Storm N et al. (2004). High-throughput MALDI-TOF discovery of genomic sequence polymorphisms. Genome Res 14: 126-133.
16. Suzuki MM, Bird A. (2008). DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9: 465-476.
17. Trent JM, Touchman JW. (2007). Cancer. The gene topography of cancer. Science 318: 1079-1080.
18. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ et al. (2007). The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113.
19. Zhang YJ, Wu HC, Shen J, Ahsan H, Tsai WY, Yang HI et al. (2007). Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clin Cancer Res 13: 2378-2384.
20. Zou HZ, Yu BM, Wang ZW, Sun JY, Cang H, Gao F et al. (2002). Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res 8: 188-191.